Quantcast

Latest Antidepressant Stories

2014-02-10 08:26:31

-- BELVIQ Now Covered by CVS Caremark -- SAN DIEGO, Calif., Feb. 10, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai has secured improved patient access of BELVIQ(®) (lorcaserin HCl) with two leading healthcare benefit companies, and that the estimated number of insured commercial lives in the United States that have coverage for BELVIQ now exceeds 50 percent. CVS Caremark customers (employers and health plans) have broadened the coverage of...

2014-02-04 23:29:33

On January 17, a US District Court granted the motion to transfer a Paxil birth defects lawsuit to the District Court for the Southern District of Texas. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Paxil side effects. San Diego, CA (PRWEB) February 04, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and...

Mental Health Boosted By Caring For A Pet
2014-02-01 06:15:20

[ Watch the Video: Can A Pet Make You More Sociable? ] Brett Smith for redOrbit.com - Your Universe Online A new study from a developmental psychologist at Tufts University has found that young people who take care of a pet tend to have stronger social relationships and bonds to their communities. “Our findings suggest that it may not be whether an animal is present in an individual’s life that is most significant but rather the quality of that relationship,” said study author,...

2014-01-29 23:31:56

National network of attorneys will resume availability to consumers inquiring about legal options to seek compensation over allegations that children suffered birth defects due to mothers’ use of SSRIs during pregnancies. San Diego, CA (PRWEB) January 29, 2014 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers who are seeking...

2014-01-13 10:28:21

Even in severe cases, most wouldn't use medications, says study in Journal of Developmental & Behavioral Pediatrics Pediatric primary care practitioners (PCPs) are reluctant to prescribe antidepressant medications to adolescent patients—even those with severe depression, reports a study in the January Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams...

2014-01-13 08:30:09

FLORHAM PARK, N.J., Jan. 13, 2014 /PRNewswire/ -- Shionogi Inc. today announced that it has entered into an exclusive, multi-year agreement with Noven Pharmaceuticals to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg, the first and only non-hormonal prescription drug approved for the treatment of moderate to severe hot flashes associated with menopause. Under the terms of the agreement, Shionogi will promote Brisdelle, along with Osphena(TM) (ospemifene), its non-estrogen oral...

2014-01-13 08:29:50

Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopausal Hot Flashes MIAMI and NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Shionogi Inc. to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg. The agreement will help extend physician awareness of the first and only FDA-approved, non-hormonal treatment for moderate to severe...

2014-01-10 08:23:35

BOSTON, Jan. 10, 2014 /PRNewswire/ -- The National Institute of Mental Health has prioritized the development of a rapidly acting treatment for depression as a key research goal. As a result, NIMH created the Rapidly Acting Treatments for Treatment Resistant Depression (RAPID) program to identify and test promising antidepressant interventions. Tal Medical's LFMS technology was selected to be tested in the first trial as part of the RAPID program. Historically, depression treatments...

2014-01-09 16:25:45

EVANSTON, Ill., Jan. 9, 2014 /PRNewswire/ -- Naurex Inc. today announced that Norbert G. Riedel, Ph.D., long-term board member and newly-appointed president and chief executive officer of Naurex, will present at the 32(nd) Annual J.P. Morgan Healthcare Conference at 3 p.m. PST on Tuesday, January 14, 2014 at the Westin St. Francis Hotel in San Francisco. Dr. Riedel will provide an overview of the company and discuss its two clinical-stage rapid-acting antidepressant drug candidates,...

2014-01-08 08:28:22

- Former Baxter International Executive Takes Helm as Neuropharmaceutical Innovator Prepares for Late-Stage Trials of its Novel Mechanism NMDA Receptor Modulators - EVANSTON, Ill., Jan. 8, 2014 /PRNewswire/ -- Naurex Inc. today announced that Norbert G. Riedel, Ph.D., has been named president and chief executive officer effective January 1, 2014. Naurex's founding chief executive officer Derek Small will continue as a director of the company. Naurex is a biopharmaceutical company...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.